Dr Bin T Teh and Dr Nick S Duesbery

Dr Teh (shown right) obtained his MD (1992) from the University of Queensland, Australia and his PhD (1997) from the Karolinska Institute, Sweden. Before joining the Van Andel Research Institute as a Senior Scientific Investigator in January 2000, he was an Associate Professor of medical genetics at the Karolinska Institute. His laboratory's goals are to identify the molecular signatures of kidney tumors and gain an understanding of how the genes function and interact to trigger the spread of cancer. His team is equally focused on developing novel biomarkers, key drug targets and animal models for drug testing in kidney tumors. He was promoted to Distinguished Scientific Investigator in 2005.

Dr Duesbery received his BSc (1987) in biology from Queen's University, Canada and both his MSc (1990) and PhD (1996) degrees in zoology from the University of Toronto, Canada. Before his appointment as a Scientific Investigator at VARI in April 1999, he was a postdoctoral fellow at the National Cancer Institute – Frederick Cancer Research and Development Center, Maryland. Dr Duesbery's research focuses mainly on mitogen-activated protein kinase kinase signaling in development and disease. He was promoted to Senior Scientific Investigator and appointed Deputy Director of Research Operations in 2006.